CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq: IVGN) today announced results for its first quarter ended March 31, 2007. Revenue for the first quarter was $309 million, an increase of 10 percent over first quarter 2006 revenue of $280 million, excluding the impact of discontinued operations.
